Usana Health Sciences Inc (USNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 94,672 | 76,636 | 79,024 | 66,433 | 50,752 |
| Depreciation Amortization | 9,978 | 8,810 | 9,044 | 8,826 | 8,474 |
| Income taxes - deferred | -2,572 | -1,039 | 814 | 4,111 | -1,599 |
| Accounts payable and accrued liabilities | 2,481 | -1,337 | 2,790 | -985 | 1,502 |
| Other Working Capital | 10,328 | 25,761 | 9,869 | 6,624 | 1,935 |
| Other Operating Activity | -3,421 | -3,646 | -2,648 | 7,796 | 9,044 |
| Operating Cash Flow | $111,466 | $105,185 | $98,893 | $92,805 | $70,108 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -23,544 | -20,411 | -8,004 | -8,278 | -10,609 |
| Net Acquisitions | -1,580 | N/A | N/A | N/A | N/A |
| Purchase Of Investment | N/A | -3,871 | -8,643 | 0 | N/A |
| Sale Of Investment | N/A | 12,511 | N/A | 0 | N/A |
| Other Investing Activity | 0 | -4,495 | -4,942 | 0 | 0 |
| Investing Cash Flow | $-25,124 | $-16,266 | $-21,589 | $-8,278 | $-10,609 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 30,000 | N/A | 1,846 | 0 |
| Common Stock Issued | N/A | 10,970 | 454 | 309 | 39 |
| Common Stock Repurchased | -61,181 | -138,819 | -18,085 | -68,294 | -33,459 |
| Other Financing Activity | 12,024 | -15,166 | 7,466 | 1,597 | 48 |
| Financing Cash Flow | $-49,157 | $-113,015 | $-10,165 | $-64,542 | $-33,372 |
| Exchange Rate Effect | -5,101 | -2,121 | -635 | 501 | 4 |
| Beginning Cash Position | 111,126 | 137,343 | 70,839 | 50,353 | 24,222 |
| End Cash Position | 143,210 | 111,126 | 137,343 | 70,839 | 50,353 |
| Net Cash Flow | $32,084 | $-26,217 | $66,504 | $20,486 | $26,131 |
| Free Cash Flow | |||||
| Operating Cash Flow | 111,466 | 105,185 | 98,893 | 92,805 | 70,108 |
| Capital Expenditure | -23,729 | -20,421 | -8,051 | -8,432 | -10,643 |
| Free Cash Flow | 87,737 | 84,764 | 90,842 | 84,373 | 59,465 |